152 related articles for article (PubMed ID: 17597266)
1. Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naïve adults.
Kim SH; Choi SJ; Park WB; Kim HB; Kim NJ; Oh MD; Choe KW
Vaccine; 2007 Aug; 25(33):6287-91. PubMed ID: 17597266
[TBL] [Abstract][Full Text] [Related]
2. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.
Pittman PR; Garman PM; Kim SH; Schmader TJ; Nieding WJ; Pike JG; Knight R; Johnston SC; Huggins JW; Kortepeter MG; Korman L; Ranadive M; Quinn X; Meyers MS
Vaccine; 2015 Jun; 33(26):2990-6. PubMed ID: 25930115
[TBL] [Abstract][Full Text] [Related]
3. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294
[TBL] [Abstract][Full Text] [Related]
4. Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults.
Treanor J; Wu H; Liang H; Topham DJ
Vaccine; 2006 Nov; 24(47-48):6913-23. PubMed ID: 17014939
[TBL] [Abstract][Full Text] [Related]
5. Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations.
Slike BM; Creegan M; Marovich M; Ngauy V
PLoS One; 2017; 12(1):e0169247. PubMed ID: 28046039
[TBL] [Abstract][Full Text] [Related]
6. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.
Kennedy JS; Frey SE; Yan L; Rothman AL; Cruz J; Newman FK; Orphin L; Belshe RB; Ennis FA
J Infect Dis; 2004 Oct; 190(7):1286-94. PubMed ID: 15346340
[TBL] [Abstract][Full Text] [Related]
7. Serological Immunity to Smallpox in New South Wales, Australia.
Costantino V; Trent MJ; Sullivan JS; Kunasekaran MP; Gray R; MacIntyre R
Viruses; 2020 May; 12(5):. PubMed ID: 32443405
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.
Kennedy JS; Gurwith M; Dekker CL; Frey SE; Edwards KM; Kenner J; Lock M; Empig C; Morikawa S; Saijo M; Yokote H; Karem K; Damon I; Perlroth M; Greenberg RN
J Infect Dis; 2011 Nov; 204(9):1395-402. PubMed ID: 21921208
[TBL] [Abstract][Full Text] [Related]
9. Absence of pharyngeal shedding of vaccinia following smallpox vaccination.
Talbot TR; Peters J; Wright PF; Edwards KM
Am J Infect Control; 2007 Sep; 35(7):486-8. PubMed ID: 17765564
[TBL] [Abstract][Full Text] [Related]
10. Persistence of cell-mediated immunity to vaccinia virus.
Kim SH; Oh MD
J Infect Dis; 2007 Sep; 196(5):805-6. PubMed ID: 17674329
[No Abstract] [Full Text] [Related]
11. Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial.
Greenberg RN; Kennedy JS; Clanton DJ; Plummer EA; Hague L; Cruz J; Ennis FA; Blackwelder WC; Hopkins RJ
Lancet; 2005 Jan 29-Feb 4; 365(9457):398-409. PubMed ID: 15680454
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.
Martínez O; Bravo Cruz A; Santos S; Ramírez M; Miranda E; Shisler J; Otero M
Vaccine; 2017 Oct; 35(44):6007-6014. PubMed ID: 28629922
[TBL] [Abstract][Full Text] [Related]
13. Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination.
Trojan A; Rajeswaran R; Montemurro M; Mütsch M; Steffen R
J Clin Virol; 2007 Sep; 40(1):80-3. PubMed ID: 17644471
[TBL] [Abstract][Full Text] [Related]
14. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
[TBL] [Abstract][Full Text] [Related]
15. Dose-related effects of smallpox vaccine.
Frey SE; Newman FK; Cruz J; Shelton WB; Tennant JM; Polach T; Rothman AL; Kennedy JS; Wolff M; Belshe RB; Ennis FA
N Engl J Med; 2002 Apr; 346(17):1275-80. PubMed ID: 11923489
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent neutralizing-antibody responses to vaccinia.
Belshe RB; Newman FK; Frey SE; Couch RB; Treanor JJ; Tacket CO; Yan L
J Infect Dis; 2004 Feb; 189(3):493-7. PubMed ID: 14745707
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers.
Jang HC; Kim CJ; Kim KH; Lee KH; Byun YH; Seong BL; Saletti G; Czerkinsky C; Park WB; Park SW; Kim HB; Kim NJ; Oh MD
Vaccine; 2010 Aug; 28(36):5845-9. PubMed ID: 20600480
[TBL] [Abstract][Full Text] [Related]
18. Cellular immune responses to diluted and undiluted aventis pasteur smallpox vaccine.
Rock MT; Yoder SM; Talbot TR; Edwards KM; Crowe JE
J Infect Dis; 2006 Aug; 194(4):435-43. PubMed ID: 16845626
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulator-based enhancement of anti smallpox immune responses.
Martínez O; Miranda E; Ramírez M; Santos S; Rivera C; Vázquez L; Sánchez T; Tremblay RL; Ríos-Olivares E; Otero M
PLoS One; 2015; 10(4):e0123113. PubMed ID: 25875833
[TBL] [Abstract][Full Text] [Related]
20. Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial.
Kim SH; Yeo SG; Jang HC; Park WB; Lee CS; Lee KD; Kim HB; Kim NJ; Kim YT; Jee Y; Cho H; Oh MD; Choe KW
J Infect Dis; 2005 Sep; 192(6):1066-70. PubMed ID: 16107961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
